Verve Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch VERV and buy or sell other stocks, ETFs, and their options commission-free!About VERV
Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A.
CEOSekar Kathiresan, MD
CEOSekar Kathiresan, MD
Employees274
Employees274
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2018
Founded2018
Employees274
Employees274
VERV Key Statistics
Market cap988.31M
Market cap988.31M
Price-Earnings ratio-5.28
Price-Earnings ratio-5.28
Dividend yield—
Dividend yield—
Average volume3.66M
Average volume3.66M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$11.41
52 Week high$11.41
52 Week low$2.86
52 Week low$2.86
Stock Snapshot
The current Verve Therapeutics(VERV) stock price is $11.13, with a market capitalization of 988.31M. The stock trades at a price-to-earnings (P/E) ratio of -5.28.
Verve Therapeutics(VERV) stock opened on 2026-01-22 at —. The price climbed to — and dipped to —.
The Verve Therapeutics(VERV)'s current trading volume is 0, compared to an average daily volume of 3.66M.
During the past year, Verve Therapeutics(VERV) stock moved between $2.86 at its lowest and $11.41 at its peak.
During the past year, Verve Therapeutics(VERV) stock moved between $2.86 at its lowest and $11.41 at its peak.
People also own
Based on the portfolios of people who own VERV. This list is generated using Robinhood data, and it’s not a recommendation.